Vizamyl
| Chemical Name | flutemetamol F 18 injection |
| Dosage Form | Injection (intravenous; 150 MBq/mL (4.05 mCi/mL) |
| Drug Class | Radioactive diagnostic agents |
| System | Nervous |
| Company | GE Healthcare |
| Approval Year | 2013 |
Indication
- For Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) or other causes of cognitive decline.